🔎 Trials Near Me

홈 › 자궁내막암 › 버지니아

버지니아의 자궁내막암 임상 시험

자궁내막암 관련 연구 57개가 버지니아 내 여러 지역에서 참여자를 모집하고 있습니다.

버지니아의 도시

공식 연구 텍스트(영어)

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

  • University of Virginia Cancer Center, Charlottesville
  • Henrico Doctor's Hospital, Richmond
피험자 모집 중2상
18세 이상 · 여성 · 2026. 11. 12. 업데이트됨 · NCT05112601

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

  • Inova Schar Cancer Institute, Fairfax
  • NEXT Virginia, Fairfax
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06270706

A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

  • NEXT Virginia, Fairfax
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT07458347

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

  • Ballad Health Cancer Care - Bristol, Bristol
  • University of Virginia Cancer Center, Charlottesville
  • Inova Schar Cancer Institute, Fairfax
  • 외 6개
피험자 모집 중2상
전 연령 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT05564377

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

  • University of Virginia Cancer Center, Charlottesville
  • Virginia Commonwealth University, Richmond
피험자 모집 중2상
18세 이상 · 여성 · 2026. 11. 12. 업데이트됨 · NCT05640999

A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer

  • Virginia Oncology Associates, Norfolk
피험자 모집 중3상
18세 이상 · 여성 · 2026. 11. 10. 업데이트됨 · NCT06340568

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

  • University of Virginia, Charlottesville
  • Virginia Cancer Specialists, Fairfax
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT07020221

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

  • Inova Schar Cancer Institute ( Site 6003), Fairfax
  • Virginia Cancer Specialists (VCS) ( Site 8008), Fairfax
  • VCU Health Adult Outpatient Pavillion ( Site 5000), Richmond
피험자 모집 중3상
18세 이상 · 여성 · 2026. 11. 10. 업데이트됨 · NCT06952504

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

  • NEXT Texas LLC - Virginia, Fairfax
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT07503808

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

  • University of Virginia Cancer Center, Charlottesville
  • VCU Massey Comprehensive Cancer Center, Richmond
피험자 모집 중3상
18세 이상 · 여성 · 2026. 11. 6. 업데이트됨 · NCT07198074

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

  • University of Virginia, Charlottesville
  • NEXT Virginia, Fairfax
피험자 모집 중1상
19세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT06586957

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

  • Virginia Commonwealth University/ Massey Cancer Center, Richmond
피험자 모집 중관찰 연구
18세 이상 · 여성 · 2026. 11. 5. 업데이트됨 · NCT05051722

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

  • USOR Virginia Cancer Specialists, Fairfax
  • USOR Virginia Oncology Associates, Norfolk
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT05579366

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

  • Inova Schar Cancer Institute, Falls Church
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06400472

Distance-Based Exercise to Preserve Function and Prevent Disability

  • Bon Secours Memorial Regional Medical Center, Mechanicsville
  • Bon Secours Saint Francis Medical Center, Midlothian
  • Bon Secours Saint Mary's Hospital, Richmond
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07059884

Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors

  • Virginia Cancer Specialists, Fairfax
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT05856981

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

  • University of Virginia, Charlottesville
피험자 모집 중3상
18세 이상 · 여성 · 2026. 11. 3. 업데이트됨 · NCT07166094

A Study to Investigate Mocertatug Rezetecan Compared With Chemotherapy in Participants With Endometrial Cancer After Platinum-based Chemotherapy and Immunotherapy (BEHOLD-Endometrial01)

  • GSK Investigational Site, Charlottesville
피험자 모집 중3상
18세 이상 · 여성 · 2026. 11. 3. 업데이트됨 · NCT07286331

CR-002 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

  • Clinical Study Site, Fairfax
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 11. 2. 업데이트됨 · NCT07909031

Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors

  • NEXT Virginia, Fairfax
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 2. 업데이트됨 · NCT07524322

Symbiotic-GYN-18: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Advanced or Recurrent MMR-proficient Endometrial Cancer

  • Virginia Oncology Associates, Chesapeake
  • Virginia Oncology Associates, Newport News
  • Virginia Oncology Associates, Norfolk
  • 외 2개
피험자 모집 중3상
18세 이상 · 여성 · 2026. 10. 30. 업데이트됨 · NCT07578649

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

  • Inova Schar Cancer Institute, Falls Church
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 29. 업데이트됨 · NCT06774963

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

  • NEXT Oncology, Fairfax
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 28. 업데이트됨 · NCT07109726

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

  • Virginia Cancer Specialists, Fairfax
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 26. 업데이트됨 · NCT06330064

Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic

  • NEXT Oncology Virginia, Fairfax
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 23. 업데이트됨 · NCT07807345

A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

  • NEXT Virginia, Fairfax
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 22. 업데이트됨 · NCT07383506

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

  • Virginia Cancer Specialists, Fairfax
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 13. 업데이트됨 · NCT06293898

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

  • Research Site, Charlottesville
  • Research Site, Fairfax
피험자 모집 중3상
18세 이상 · 여성 · 2026. 10. 13. 업데이트됨 · NCT06989112

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

  • NEXT, Fairfax
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 13. 업데이트됨 · NCT06993844

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

  • University of Virginia, Charlottesville
피험자 모집 중1상
15세 이상 · 모든 성별 · 2026. 10. 9. 업데이트됨 · NCT06276491

FOG-001 in Locally Advanced or Metastatic Solid Tumors

  • University of Virginia, Charlottesville
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 7. 업데이트됨 · NCT05919264

Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors

  • Research Site, Fairfax
피험자 모집 중1/2상
18세 ~ 130세 · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT05797168

A Study of PHST001 in Advanced Solid Tumors

  • NEXT Oncology - Virginia, Fairfax
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT06840886

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • Virginia Cancer Specialists, Fairfax
피험자 모집 중1/2상
12세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT04585750

A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors

  • Site 04, Fairfax
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT07814248

Study of AVZO-021 in Patients With Advanced Solid Tumors

  • Avenzo Therapeutics Recruiting Site, Fairfax
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT05867251

Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers

  • Virginia Commonwealth University, Richmond
피험자 모집 중1/2상
18세 이상 · 여성 · 2026. 9. 25. 업데이트됨 · NCT03564340

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • NEXT Oncology Virginia, Fairfax
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT06128551

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

  • Virginia Cancer Specialists, Fairfax
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 21. 업데이트됨 · NCT05983432

Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.

  • NEXT Oncology, Fairfax
피험자 모집 중1상
18세 이상 · 여성 · 2026. 9. 3. 업데이트됨 · NCT07755436

ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.